Form 4 for WGS GeneDx Holdings Corp.
Accepted 2022-11-28 00:00:00 ET · period of report 2022-11-28 · accession 0001209191-22-058889 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-11-28 | 2022-11-28 | WGS | Stueland Katherine | CEO, Dir | P - Purchase | $0.54 | +185.2K | 185.2K | New | +$100.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2022-11-28 | P | A | 185,185 | $0.54 | 185,185 | D | — | — |